Are NICE’s current methods for assessing cost-effectiveness ‘fit for purpose’ for the appraisal of regenerative medicines?

Sebastian Hinde; Stephen John Palmer; Robert Hettle

Are NICE’s current methods for assessing cost-effectiveness ‘fit for purpose’ for the appraisal of regenerative medicines?

Sebastian Hinde, Stephen John Palmer, Robert Hettle

Centre for Health Economics

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 4 Jan 2016
Event	Health Economics Study Group (HESG) - Manchester, United Kingdom Duration: 3 Jan 2016 → 6 Jan 2016

Conference

Conference	Health Economics Study Group (HESG)
Country/Territory	United Kingdom
City	Manchester
Period	3/01/16 → 6/01/16

Cite this

@conference{4de5d22d90f847ed8b1467f8e1f93d99,

title = "Are NICE{\textquoteright}s current methods for assessing cost-effectiveness {\textquoteleft}fit for purpose{\textquoteright} for the appraisal of regenerative medicines?",

author = "Sebastian Hinde and Palmer, {Stephen John} and Robert Hettle",

year = "2016",

month = jan,

day = "4",

language = "English",

note = "Health Economics Study Group (HESG) ; Conference date: 03-01-2016 Through 06-01-2016",

}